Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | APC |
| Variant | T1556Nfs*3 |
| Impact List | frameshift |
| Protein Effect | loss of function |
| Gene Variant Descriptions | APC T1556Nfs*3 indicates a shift in the reading frame starting at amino acid 1556 and terminating 3 residues downstream causing a premature truncation of the 2843 amino acid Apc protein (UniProt.org). T1556Nfs*3 retains binding with Axin1 but confers a loss of function to Apc as demonstrated by decreased beta-catenin recruitment, phosphorylation, and ubiquitination in cultured cells (PMID: 34352208). |
| Associated Drug Resistance | |
| Category Variants Paths |
APC mutant APC inact mut APC T1556fs APC T1556Nfs*3 |
| Transcript | NM_000038.6 |
| gDNA | chr5:g.112840260dupA |
| cDNA | c.4666dupA |
| Protein | p.T1556Nfs*3 |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_001354895.1 | chr5:g.112840260dupA | c.4666dupA | p.T1556Nfs*3 | RefSeq | GRCh38/hg38 |
| NM_001354900.2 | chr5:g.112840383_112840384insACCCCTAA | c.4666_4667insACCCCTAA | p.T1556Nfs*3 | RefSeq | GRCh38/hg38 |
| NM_001127510.3 | chr5:g.112840260dupA | c.4666dupA | p.T1556Nfs*3 | RefSeq | GRCh38/hg38 |
| NM_001354902.2 | chr5:g.112840534delC | c.4667delC | p.T1556Nfs*3 | RefSeq | GRCh38/hg38 |
| NM_001354895.2 | chr5:g.112840260dupA | c.4666dupA | p.T1556Nfs*3 | RefSeq | GRCh38/hg38 |
| NM_001127510 | chr5:g.112840258_112840259insG | c.4664_4665insG | p.T1556Nfs*3 | RefSeq | GRCh38/hg38 |
| NM_001127510.2 | chr5:g.112840260dupA | c.4666dupA | p.T1556Nfs*3 | RefSeq | GRCh38/hg38 |
| NM_000038.5 | chr5:g.112840260dupA | c.4666dupA | p.T1556Nfs*3 | RefSeq | GRCh38/hg38 |
| NM_001407450.1 | chr5:g.112840260dupA | c.4666dupA | p.T1556Nfs*3 | RefSeq | GRCh38/hg38 |
| NM_000038.6 | chr5:g.112840260dupA | c.4666dupA | p.T1556Nfs*3 | RefSeq | GRCh38/hg38 |
| NM_000038 | chr5:g.112840258_112840259insG | c.4664_4665insG | p.T1556Nfs*3 | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| APC T1556Nfs*3 | desmoid tumor | predicted - sensitive | Celecoxib + Nirogacestat | Case Reports/Case Series | Actionable | In a clinical case study, addition of Ogsiveo (nirogacestat) to Celecoxib treatment resulted in a reduction in tumor size and stable disease that was ongoing for at least 17 months in a pediatric patient with a desmoid tumor harboring APC T1556Nfs*3 (PMID: 32762028). | 32762028 |